Safety and Effectiveness of Dupilumab in Prurigo Nodularis
Ciro Romano
Abstract
Figure.Upper panel: diffuse involvement of skin by PN lesions immediately before starting dupilumab treatment.Lower panel: complete resolution of skin lesions at the 3-month follow-up visit.Only depigmented lesions on intact skin are visible.
Topics & Concepts
DupilumabPrurigo nodularisMedicineDermatologyAtopic dermatitisDermatology and Skin DiseasesMedicine and Dermatology Studies HistoryAutoimmune Bullous Skin Diseases